Strongbridge Biopharma Plc Announces Closing Of Public Offering Of Ordinary Shares

Strongbridge Biopharma plc, today announced the closing of its previously announced underwritten public offering of 4,000,000 ordinary shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.